Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at CARDINAL HEALTH INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CARDINAL HEALTH INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CARDINAL HEALTH INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Jessica L. Mayer
Chief Legal and Compliance Officer
Total Cash $1,559,125 Equity $3,084,840 Other $13,800 Total Compensation $4,657,765
Stephen M. Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
Total Cash $1,348,341 Equity $5,973,322 Other $13,800 Total Compensation $7,335,463
Jason M. Hollar
Chief Executive Officer
Total Cash $4,546,265 Equity $20,640,912 Other $463,532 Total Compensation $25,650,709
Deborah L. Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
Total Cash $1,467,947 Equity $3,598,977 Other $19,063 Total Compensation $5,085,987
Aaron E. Alt
Chief Financial Officer
Total Cash $2,000,034 Equity $4,824,118 Other $17,849 Total Compensation $6,842,001
For its 2024 fiscal year, CARDINAL HEALTH INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Jason M. Hollar CEO Pay $25,665,055 Median Employee Pay $56,119 CEO Pay Ratio 457:1
For its 2024 fiscal year, CARDINAL HEALTH INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Akhil Johri Total Cash $345,088
Bruce L. Downey Total Cash $43,257
Carrie S. Cox Total Cash $52,764
Christine A. Mundkur Total Cash $318,088
David C. Evans Total Cash $322,088
Gregory B. Kenny Total Cash $570,098
Michelle M. Brennan Total Cash $318,088
Nancy Killefer Total Cash $330,609
Patricia A. Hemingway Hall Total Cash $338,088
Robert W. Azelby Total Cash $182,658
Sheri H. Edison Total Cash $338,088
Steven K. Barg Total Cash $318,088
Sujatha Chandrasekaran Total Cash $320,088

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.